SG11202006723SA - Non-fused thiophene derivatives and their uses - Google Patents
Non-fused thiophene derivatives and their usesInfo
- Publication number
- SG11202006723SA SG11202006723SA SG11202006723SA SG11202006723SA SG11202006723SA SG 11202006723S A SG11202006723S A SG 11202006723SA SG 11202006723S A SG11202006723S A SG 11202006723SA SG 11202006723S A SG11202006723S A SG 11202006723SA SG 11202006723S A SG11202006723S A SG 11202006723SA
- Authority
- SG
- Singapore
- Prior art keywords
- thiophene derivatives
- fused thiophene
- fused
- derivatives
- thiophene
- Prior art date
Links
- 150000003577 thiophenes Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305134 | 2018-02-08 | ||
| PCT/EP2019/053081 WO2019154956A1 (en) | 2018-02-08 | 2019-02-08 | Non-fused thiophene derivatives and their uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202006723SA true SG11202006723SA (en) | 2020-08-28 |
Family
ID=61283124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202006723SA SG11202006723SA (en) | 2018-02-08 | 2019-02-08 | Non-fused thiophene derivatives and their uses |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US11767316B2 (en) |
| EP (2) | EP3749649A1 (en) |
| JP (1) | JP7399110B2 (en) |
| KR (2) | KR20240131460A (en) |
| CN (1) | CN111936471A (en) |
| AU (1) | AU2019219123B2 (en) |
| BR (1) | BR112020015743A2 (en) |
| CA (1) | CA3087830A1 (en) |
| CO (1) | CO2020009106A2 (en) |
| EA (1) | EA202091897A1 (en) |
| IL (1) | IL275893B2 (en) |
| MX (1) | MX2020007917A (en) |
| PH (1) | PH12020551175A1 (en) |
| SG (1) | SG11202006723SA (en) |
| WO (2) | WO2019154956A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3749649A1 (en) | 2018-02-08 | 2020-12-16 | ENYO Pharma | Non-fused thiophene derivatives and their uses |
| US11603368B2 (en) | 2018-02-08 | 2023-03-14 | Enyo Pharma | Fused thiophene derivatives and their uses |
| CA3150673A1 (en) | 2019-10-17 | 2021-04-22 | Enyo Pharma | Thiophene derivatives for use in treating portal inflammation and fibrosis |
| TW202128675A (en) | 2019-12-06 | 2021-08-01 | 美商維泰克斯製藥公司 | Substituted tetrahydrofurans as modulators of sodium channels |
| JP7429799B2 (en) | 2020-02-18 | 2024-02-08 | ギリアード サイエンシーズ， インコーポレイテッド | antiviral compounds |
| TWI775313B (en) | 2020-02-18 | 2022-08-21 | 美商基利科學股份有限公司 | Antiviral compounds |
| TW202322824A (en) | 2020-02-18 | 2023-06-16 | 美商基利科學股份有限公司 | Antiviral compounds |
| EP4185381A4 (en) * | 2020-07-24 | 2024-08-21 | Inipharm Inc | Thiophene hsd17b13 inhibitors and uses thereof |
| CA3185691A1 (en) | 2020-08-05 | 2022-02-10 | Enyo Pharma | Thiophen compounds for use in the treatment of renal fibrosis |
| CN112851633B (en) * | 2021-01-19 | 2021-12-07 | 上海应用技术大学 | 2-aminothiophene neuraminidase inhibitor and preparation method and application thereof |
| EP4323362A1 (en) | 2021-04-16 | 2024-02-21 | Gilead Sciences, Inc. | Methods of preparing carbanucleosides using amides |
| PE20241335A1 (en) | 2021-06-04 | 2024-07-03 | Vertex Pharma | N-(HYDROXYALKYL (HETERO)ARYL) TETRAHYDROFURAN CARBOXAMIDES AS SODIUM CHANNEL MODULATORS |
| US12116380B2 (en) | 2021-08-18 | 2024-10-15 | Gilead Sciences, Inc. | Phospholipid compounds and methods of making and using the same |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9924092D0 (en) | 1999-10-13 | 1999-12-15 | Zeneca Ltd | Pyrimidine derivatives |
| US20050085531A1 (en) * | 2003-10-03 | 2005-04-21 | Hodge Carl N. | Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof |
| DE10359791A1 (en) | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituted thiophenes |
| US8263641B2 (en) * | 2007-09-10 | 2012-09-11 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| US8389567B2 (en) * | 2007-12-12 | 2013-03-05 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
| CN102256969A (en) | 2008-08-27 | 2011-11-23 | 钙医学公司 | Compounds that modulate intracellular calcium |
| US20110319416A1 (en) | 2009-01-28 | 2011-12-29 | Emory University | Subunit Selective NMDA Receptor Antagonists For The Treatment Of Neurological Conditions |
| US20130085133A1 (en) | 2010-02-08 | 2013-04-04 | Sourthern Research Institute Office of Commercialization and Intellectual Prop. | Anti-viral treatment and assay to screenfor anti-viral agent |
| WO2013142628A2 (en) * | 2012-03-20 | 2013-09-26 | Fred Hutchinson Cancer Research Center | Antibiotic compounds and compositions, and methods for identification thereof |
| EP2679591A1 (en) * | 2012-06-29 | 2014-01-01 | Poxel | Thienopyridone derivatives useful as activators of AMPK |
| US20170114060A1 (en) * | 2014-06-03 | 2017-04-27 | The Trustees Of The University Of Pennsylvania | Novel effective antiviral compounds and methods using same |
| CN106687446B (en) | 2014-07-18 | 2020-04-28 | 百济神州(北京)生物科技有限公司 | 5-amino-4-carbamoyl-pyrazole compounds as selective and irreversible kinase inhibitors of T790M/WT-EGFR and uses thereof |
| CN110114349B (en) | 2016-12-29 | 2022-03-15 | 埃尼奥制药公司 | Thiophene derivatives as antiviral agents |
| EP3749649A1 (en) | 2018-02-08 | 2020-12-16 | ENYO Pharma | Non-fused thiophene derivatives and their uses |
| US11603368B2 (en) | 2018-02-08 | 2023-03-14 | Enyo Pharma | Fused thiophene derivatives and their uses |
| US20210038566A1 (en) | 2018-02-08 | 2021-02-11 | Enyo Pharma | Use of modulators of neet proteins for the treatment of infection |
-
2019
- 2019-02-08 EP EP19703332.7A patent/EP3749649A1/en active Pending
- 2019-02-08 CA CA3087830A patent/CA3087830A1/en active Pending
- 2019-02-08 US US16/967,744 patent/US11767316B2/en active Active
- 2019-02-08 EP EP19703333.5A patent/EP3749650A1/en active Pending
- 2019-02-08 BR BR112020015743-0A patent/BR112020015743A2/en unknown
- 2019-02-08 CN CN201980012287.0A patent/CN111936471A/en active Pending
- 2019-02-08 EA EA202091897A patent/EA202091897A1/en unknown
- 2019-02-08 US US16/967,753 patent/US11840527B2/en active Active
- 2019-02-08 KR KR1020247027773A patent/KR20240131460A/en not_active Application Discontinuation
- 2019-02-08 KR KR1020207023770A patent/KR20200141026A/en active Application Filing
- 2019-02-08 MX MX2020007917A patent/MX2020007917A/en unknown
- 2019-02-08 WO PCT/EP2019/053081 patent/WO2019154956A1/en unknown
- 2019-02-08 JP JP2020565534A patent/JP7399110B2/en active Active
- 2019-02-08 IL IL275893A patent/IL275893B2/en unknown
- 2019-02-08 AU AU2019219123A patent/AU2019219123B2/en active Active
- 2019-02-08 SG SG11202006723SA patent/SG11202006723SA/en unknown
- 2019-02-08 WO PCT/EP2019/053077 patent/WO2019154953A1/en unknown
-
2020
- 2020-07-24 CO CONC2020/0009106A patent/CO2020009106A2/en unknown
- 2020-08-03 PH PH12020551175A patent/PH12020551175A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3749649A1 (en) | 2020-12-16 |
| US20210040059A1 (en) | 2021-02-11 |
| JP7399110B2 (en) | 2023-12-15 |
| WO2019154953A1 (en) | 2019-08-15 |
| EA202091897A1 (en) | 2020-10-27 |
| EP3749650A1 (en) | 2020-12-16 |
| AU2019219123B2 (en) | 2022-12-08 |
| KR20240131460A (en) | 2024-08-30 |
| JP2021514385A (en) | 2021-06-10 |
| IL275893A (en) | 2020-08-31 |
| WO2019154956A1 (en) | 2019-08-15 |
| PH12020551175A1 (en) | 2021-06-07 |
| MX2020007917A (en) | 2020-10-28 |
| AU2019219123A1 (en) | 2020-08-06 |
| US20200369655A1 (en) | 2020-11-26 |
| IL275893B2 (en) | 2024-08-01 |
| KR20200141026A (en) | 2020-12-17 |
| US11840527B2 (en) | 2023-12-12 |
| CN111936471A (en) | 2020-11-13 |
| CA3087830A1 (en) | 2019-08-15 |
| US11767316B2 (en) | 2023-09-26 |
| IL275893B1 (en) | 2024-04-01 |
| BR112020015743A2 (en) | 2020-12-15 |
| CO2020009106A2 (en) | 2020-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL275893A (en) | Non-fused thiophene derivatives and their uses | |
| IL284100A (en) | N4-hydroxycytidine and derivatives and anti-viral uses related thereto | |
| IL275905A (en) | Fused thiophene derivatives and their uses | |
| HK1246156B (en) | Fgf21 derivatives and uses thereof | |
| IL271290A (en) | Dihydro-pyrrolo-pyridine derivatives | |
| EP3535243A4 (en) | Tricyclic heterocyclic derivatives and uses thereof | |
| IL278770A (en) | Thiophene derivatives, their preparation and use | |
| PT3796975T (en) | Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives | |
| SG11202008543RA (en) | Pyrrolidineamide derivatives and uses thereof | |
| SG11202010985TA (en) | Heterocyclic derivatives and use thereof | |
| IL282527A (en) | Azaindazole-5 derivatives and their use | |
| IL278973A (en) | Novel benzodiazepine derivatives and uses thereof | |
| IL279938A (en) | Spirochromane derivatives | |
| IL282526A (en) | Azaindazole-5 derivatives and their use | |
| IL275935A (en) | Thiophene derivative and use thereof | |
| PL3770162T3 (en) | Dihydrochromene derivatives | |
| HK1253072A1 (en) | Podophyllotoxin derivatives and their use | |
| GB201806948D0 (en) | Derivatives |